Introduction
B cell chronic lymphocytic leukemia is a disease with a low proliferative activity characterized by the accumulation of clonal B lymphocytes that seem to be arrested in early G0/G1 phase of the cell cycle. 1 Although the pathogenesis of the disease remains largely unknown, previous investigations have focused on the defective apoptosis of the malignant cells that seems to play an important role in disease progression and chemotherapy resistance. [2] [3] [4] There is additional evidence that the deregulation of cell cycle regulatory genes may contribute to the expansion of the malignant clone. 5 Overexpression of cyclin D2 mRNA has been described in B-CLL cells 6 and expression of the cyclin-dependent kinase (cdk) inhibitor p27, a key regulator of the early phase of the cell cycle, has been recently demonstrated to be elevated in B-CLL cells. 7 Contrary to previous reports in solid tumors, 8, 9 high p27 levels were associated with a poorer outcome in B-CLL. 7 Passage through the restriction point and entry into the S phase is regulated by an interplay between cyclins, serine/threonine cyclin dependent kinases, and cdk inhibitors. Depending on the cell type, G1 progression is dependent on the appearance of cyclins D1, D2 or D3 in association with either cdk4 or cdk6, resulting in phosphorylation of the retinoblastoma (RB) protein. 10 While cdk activity requires cyclin binding, it can be constrained by at least two families of cdk inhibitory proteins. 11 Cyclin D3, cdk6 and the cdk inhibitor p27 have been described to be the most important regulators of G1 progression in human B cells following stimulation with anti-IgM, CD40 ligation and a variety of cytokines. 12, 13 While cyclin D1 is not detectable in resting or activated human B cells, cyclin D1 overexpression is the hallmark of mantle cell lymphoma and a consequence of the (11, 14) translocation. 14 Cyclin D2 is only weakly regulated in activated human B cells, 12 but is important for G1 progression im murine B cells 15, 16 and is overexpressed in EBV-transformed B cells.
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D-type cyclins are considered to act primarily as growth factor sensors that are induced as part of the delayed early response to mitogens. 18 B-CLL cells clearly demonstrate a marked hyporesponsiveness to a variety of polyclonal B cell activators. 19, 20 Therefore, investigating the regulation of D-type cyclins should contribute to the understanding of B-CLL pathophysiology. We have recently shown that B-CLL cell proliferation can be induced by stimulation with CpG-oligonucleotides (CpG-ODN), 21 which activate cells of the immune system in a sequence-dependent manner. The immunostimulatory properties of bacterial DNA and mimicking synthetic oligonucleotide sequences have only recently been recognized (for review see Refs 22 and 23) . Although the proliferative response to CpG stimulation alone was somewhat reduced compared to normal peripheral B cells, addition of IL-2 caused a strong increase of thymidine incorporation in B-CLL cells. 24 Therefore, stimulation with CpG-ODN with or without IL-2 provides a valuable model for investigating cell cycle regulation in normal and malignant B cells. In the present study, we analyzed cell cycle entry and the expression of D-type cyclins, cdk4, cdk6 and p27 and the phosphorylation status of the retinoblastoma protein in B-CLL cells and tonsillar B cells in response to CpG-ODN, IL-2 and a combination of both.
Materials and methods

Cell samples
After informed consent, peripheral blood was obtained from patients with a diagnosis of B-CLL according to clinical and immunophenotypic criteria. Patients were either untreated or had not received cytoreductive chemotherapy for a period of at least 3 months prior to investigation. At the time of analysis all patients were clinically stable, free from infectious complications and undergoing routine clinical out-patient review. For control experiments tonsillar specimen were collected from patients undergoing routine tonsillectomy.
Reagents and antibodies
All ODN were used single-stranded, phosphorothioate-stabilized and synthesized by TibMolBiol (Berlin, Germany). The following ODN were used: DSP30 (TCGTCGCTGTCTCC
Separation procedures
Peripheral blood mononuclear cells (PBMNC) were isolated from heparinized blood samples by centrifugation over a Ficoll-Hypaque layer (Biochrom, Berlin, Germany) of 1.077 g/ml density. For separation of CLL B cells, PBMNC were incubated with anti-CD2 and anti-CD14 magnetic beads (Dynabeads M450; Dynal, Oslo, Norway) according to the manufacturer ‡s instructions. Such prepared B cells from CLL patients were Ͼ98% pure as assessed by direct immunofluorescence using a Coulter Epics XL (Coulter, Hamburg, Germany). Purification of tonsillar B cell fraction was performed by negative selection as described for CLL-B cells.
Culture conditions
Purified normal and leukemic B cells were cultured in RPMI 1640 medium (Biochrom) supplemented with 10% fetal calf serum (Biochrom), penicillin/streptomycin 50 IU/ml, Napyruvate 1 mm, l-glutamine 2 mm, l-asparagine 20 g/ml, 2-mercaptoethanol 0.05 mm, HEPES 10 mm and MEM nonessential amino acids 0.7× (Biochrom at 37°C and 5% CO 2 in a fully humidified atmosphere in 12-well plates at 5 × 10 6 cells in a total volume of 5 ml. 
H-thymidine uptake
Cell cycle analysis
Approximately 10 6 cells were collected and fixed overnight in 70% ethanol at 4°C. Cells were then washed and stained with propidium iodide (PI) (Sigma, Deisenhofen, Germany) 5 g/ml in the presence of DNAse free RNAse (Sigma). After 30 min at room temperature, the cells were analyzed via flow cytometry using a Coulter Epics XL cytofluorometer, acquiring 10 000 events.
Immunoblotting
A total of 1 to 2 × 10 7 cells were lysed as previously described 27 in lysis buffer (10 mm Tris-HCl (pH 7. 
Immunoprecipitations
Cell extracts were prepared as described above. Cell extracts containing 350 g of total protein were immunoprecipitated by incubating with either Ab against cyclin D2 (2 g), cyclin D3 (2 g) or cdk4 (2 g) overnight at 4°C with rocking.
Immune complexes were precipitated with 30 l protein ASepharose (Pharmacia Biotech, Freiburg, Germany), washed three times in lysis buffer, followed by separation on SDSpolyacrylamide gels. Blots were developed as described above.
In vitro kinase asssay
For RB kinase assays, whole cell extracts were prepared by resuspending the cells on ice in Tween 20 lysis buffer (50 mmol/l Hepes (pH 7.5), 150 mmol/l NaCl, 1 mmol/l EDTA (pH 8.0), 2.5 mmol/l EGTA (pH 8.0), 0.1% Tween 20, 10% glycerol, 1 mmol/l DTT, 1 mmol/l NaF, 0.1 mmol/l Na 3 VO 4 and 10 mg/ml of each phenantroline, aprotinin, leupeptin and pepstatin). Cell lysates were precleared by incubation with a polyclonal rabbit anti-mouse antibody and protein Asepharose. Immunprecipitation of cyclin D2 and cyclin D3 complexes was performed as described above. After washing twice in Tween 20 lysis, once in Tween lysis buffer containing 500 mmol/l NaCl, once in H 2 O and three times in kinase buffer (50 mmol/l Hepes (pH 7.5), 10 mmol/l MgCl 2 , 1 mmol/l DTT, 2 mmol/l EGTA, 1 mmol/l NaF, 0.1 mmol/l Na 3 VO 4 , 10 mmol/l ␤-glycerophosphate), the reaction was started in 25 l kinase buffer containing 20 mol/l ATP, 0.5 g truncated retinoblastoma p56RB protein (QED Bioscience, San Diego, CA, USA), 10 Ci ␥ 32 P-ATP 5000 Ci/mmol, Amersham, Freiburg, Germany). After 30 min at 30°C, the reaction was terminated by boiling the samples in 2 × SDS sample buffer for 10 min. The phosphorylated substrate was then identified by resolution in 10% SDS page followed by drying and autoradiography.
Results
Cell cycle progression of B-CLL cells in response to phosphothioate-ODNs and IL-2
To quantify the percentage of cells traversing through the cell cycle, purified B-CLL cells were cultured with the CpG-ODN DSP30 or the control ODN pZ2 lacking the CpG dinucleotide with or without IL-2. After a culture period of 48 h, cell cycle progression was assessed by determining the percentage of cells in S/M/G2 phase using flow cytometric analysis. While nearly all cells were arrested in G0/G1 phase after culture in medium alone or with IL-2 as the only stimulus, stimulation with DSP30 caused a significant entry of B-CLL cells into the cell cycle. Addition of IL-2 strongly augmented the percentage of B-CLL cells in S/M/G2 phase. The non-CpG-ODN pZ2 did not induce significant cell cycle entry when used as the only stimulus, but a costimulatory effect with IL-2 was observed. One representative PI stain and the mean percentage of cells in S/M/G2 phase of seven independent experiments are depicted in Figure 1 .
Analysis of D-type cyclins, p27 and RB phosphorylation in B-CLL cells after stimulation with DSP30 and IL-2
During a time course of 96 h, maximal thymidine incorporation could be observed in B-CLL cells stimulated with DSP30 and IL-2 after 48 and 72 h. In contrast, stimulation with DSP30 alone induced only moderate thymidine incorporation. One representative experiment out of three performed is presented Figure 2a . The expression of the D-type cyclins and the cdk inhibitor p27, which are key regulatory proteins for G1 progression, 18 was analyzed by Western blotting after harvesting the cells at the indicated time ( Figure 2b ). As previously reported, 7 the level of p27 was high in resting B-CLL cells, but rapidly fell below the detection level upon stimulation with DSP30 or DSP30 and IL-2. While no expression of cyclin D1 could be observed, cyclins D2 and D3 were weakly induced when B-CLL cells were stimulated with DSP30 alone with a more pronounced effect on cyclin D2 expression. Addition of IL-2 resulted in a rapid and strong induction of cyclin D2 and cyclin D3. The expression of cyclin D2 was very similar in three additional experiments, but cyclin D3 expression was weaker and peaked at later time-points in two samples (data not shown). It is believed that RB phosphorylation identifies H incorporation was measured (a). P27 was revealed by immunoblotting with mAB in total cell lysates (20 g). The same membrane was sequentially stripped and probed with anti-cyclin D1, anti-cyclin D2 and anti-cyclin D3. Recombinant cyclin D1 was used as a positive control (pc) for D1. Hypophosphorylated (pRB) and hyperphosphorylated RB (ppRB) were detected with the G3-245 mAB (b). Protein concentrations were normalized by the BioRad assay method. To control for equal protein loading, amido black staining was performed (data not shown).
the restriction point in G1 of the cell cycle. 10 Therefore, we analyzed RB protein expression using a mAB that recognizes hypophosphorylated and hyperphosphorylated RB protein. As shown in Figure 2b , phosphorylation occurred after stimulation with DSP30 alone, but was strongly enhanced when IL-2 was added with nearly all RB protein being hyperphosphorylated after 24 or 48 h of activation.
The non-CpG-ODN pZ2 regulates cyclin D2 and D3 expression in B-CLL cells only with IL-2 as a costimulus
Activation of human B cells using ODN is less restricted to the CpG motif than stimulation of murine B cells, but the CpG-motif is required for optimal activation. 21 To evaluate the importance of the CpG-motif for cell cycle regulation, we stimulated B-CLL cells with the non-CpG-ODN pZ2 with or without IL-2. Only minimal proliferation was observed using pZ2 as the only stimulus. Addition of IL-2, however, enhanced thymidine incorporation at subsequent time-points (Figure 3a) .
Figure 3
Effect of the non-CpG ODN pZ2 on regulation of D-type cyclins, p27 and RB phosphorylation. Purified B-CLL cells were activated with the non-CpG-ODN pZ2 or pZ2 and IL-2 and thymidine incorporation (a), expression of p27, cyclin D2 and cyclin D3 and RB expression and phosphorylation were analyzed as described in Figure 2 (b).
In accordance with the proliferation data, no regulation of cyclin D2 and D3 could be detected after activation with pZ2 alone (Figure 3b) . However, addition of IL-2 resulted in induction of cyclin D2 and D3 after 48 h of culture. This effect occurred much later and was less pronounced than upon stimulation with IL-2 and DSP30. Accordingly, only limited RB-protein phosphorylation occurred after 72 h in culture which is in striking contrast to the rapid RB phosphorylation observed in response to DSP30 and IL-2 (Figures 2b and 3b) . Although limited proliferative responses were seen, a downregulation of p27 levels below the detection level was noted after stimulation with pZ2 for 72 h. This effect was strongly enhanced when IL-2 was added to the cultures (Figure 3b) .
Stimulation with IL-2 alone does not affect protein levels of cyclin D2 and D3, but results in downregulation of the p27 protein
Although IL-2 has been described to be a growth factor for B-CLL cells in a small proportion of patients without additional stimuli, 28 we have not observed significant proliferation even in those samples which expressed the CD25 antigen. 24 No significant thymidine incorporation could be detected in B-CLL cells cultured with IL-2 for up to 96 h (data not shown) in three independent experiments. In line with the proliferation data, no regulation of cyclin D2 and D3 or phosphorylation of the RB protein was observed (Figure 4a ). In contrast, down-regulation of p27 protein levels was observed in all three experiments, but the protein was still detectable after 96 h. This effect was not due to increased spontaneous degradation of p27 in B-CLL cells because culture in medium alone did not result in p27 down-regulation (Figure 4b ).
Cell cycle regulation in human tonsillar B cells
To compare cell cycle regulation of B-CLL cells with normal B cells, thymidine incorporation and expression of regulatory proteins were evaluated at the indicated time-points in purified tonsillar B cells. Following a time course of 96 h, thymidine incorporation of tonsillar B cells stimulated with DSP30 was higher than in B-CLL cells and was only moderately enhanced when IL-2 was added (Figure 5a ). Cyclin D3 and D2 are both induced upon stimulation with DSP30 but stronger and earlier expression of cyclin D3 was observed (Figure 5b ). Addition of IL-2 slightly enhanced cyclin D2 expression, but had no further effect on cyclin D3 protein levels. In contrast to B-CLL cells, where a rapid downregulation of p27 protein levels below the detection level was noted, p27 expression in tonsillar B cells was only moderately reduced after stimulation with DSP30 and returned to baseline levels after 96 h of culture. Although addition of IL-2 had no effect on protein levels at earlier time-points, p27 expression after 96 h of stimulation was still reduced compared to baseline levels.
Cyclin D2 and cyclin D3 are both associated with cdk4 in activated B-CLL cells and mediate RB phosphorylation in vitro
We examined the expression of cdk4 and cdk6, the catalytic partners of D-type cyclins in B-CLL cells stimulated with DSP30 and IL-2. Both cdks were expressed at high levels, but IL-2 alone does not upregulate cyclin D2 or cyclin D3, but results in downregulation of the p27 protein. B-CLL cells were cultured with 100 U/ml IL-2 and total cell lysates were prepared at 24 h, 48 h, 72 h and 96 h. Immunoblotting with mAB against p27, cyclin D2, cyclinD3 and RB was performed as described in Materials and methods and in Figure 2 . We included total cell lysates of cells stimulated by DSP30 and IL-2 for 24 h as a positive control (pc) for cyclin D2 and D3 expression (a). Total cell lysates were prepared after the indicated times of in vitro culture in medium alone and 20 g were subjected to Western blotting using a mAB against p27 (b).
showed no significant regulation during the time period examined ( Figure 6a ). Next we sought to examine whether cdk4 or cdk6 were associated with cyclin D3 and cyclin D2. Total cell extracts from B-CLL cells stimulated with DSP30 and IL-2 were immunoprecipitated with either cyclin D3 or cyclin D2 Ab. Cyclin D3 and cyclin D2 immune complexes were probed with cdk4 or cdk6 mAb. Both cyclins were associated with cdk4 but no cyclin-cdk6 complexes could be detected (Figure 6b ). In addition, both cyclins could be detected in cdk4 immune complexes of activated, but not of resting B-CLL cells (data not shown). Because cyclin D3 is considered to be the principal D-type cyclin that mediates G1 progression in human B cells, 12, 13 we investigated the ability of cyclin D2 and cyclin D3 complexes to phosphorylate the RB protein in vitro. Lysates of B-CLL cells stimulated with DSP30 and IL-2 for various time-points were immunoprecipitated with either cyclin D2 or cyclin D3 Ab. Immunoprecipitates were then incubated in the presence of RB substrate, ␥ 32 P-ATP, and kinase activity was analyzed by autoradiographic analysis. Cyclin D2 and cyclin D3 immune complexes were both able to
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Figure 5
Analysis of D-type cyclin and p27 expression upon stimulation with the CpG-ODN DSP30 in tonsillar B cells. Purified tonsillar B cells were cultivated for up to 96 h in the presence of DSP30 or DSP30 and IL-2. DNA synthesis and expression of cyclin D2, cyclin D3 and p27 were analysed as described in Figure 2 .
mediate RB phosphorylation with a stronger kinase activity at later time-points, reflecting the high percentage of phosphorylated RB protein upon stimulation with DSP30 and IL-2 ( Figure 2b) . We included cyclin D3 and anti-IgM immunoprecipitates from proliferating Raji cells as a positive and negative control, respectively. One representative experiment is shown in Figure 7 , two additional experiments gave similar results.
Discussion
B-CLL cells are arrested in G0 or rather early G1 phase of the cell cycle 1 and demonstrate a marked hyporesponsiveness to a variety of polyclonal B cell activators. 19, 20 Therefore, analysis of the cell cycle machinery during early cell cycle progression upon suboptimal and optimal stimulation seems to be a promising approach to detect quantitative or qualitative differences in cell cycle regulation in B-CLL. We have recently demonstrated that immunostimulatory CpG-ODN induce proliferation in B-CLL cells that is markedly enhanced upon addition of IL-2 to the cultures 21, 24 and a large fraction of cells could be induced to traverse the cell cycle using these stimuli (Figure 1) . Stimulation of human B cells, however, is not
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Figure 6
Cyclin D2 and cyclin D3 are associated with cdk4 and not cdk6 in activated B-CLL cells. Cdk4 and cdk6 expression were analyzed in cell lysates from B-CLL cells stimulated with DSP30 and IL-2 over a time period of 96 h by immunoblotting with cdk4 and cdk6 Ab (a). Total cellular extracts were immunoprecipitated with cyclin D2 and cyclin D3 Ab and were probed with cdk4 and cdk6 Ab, respectively. As a control, membranes were stripped and reprobed with cyclin D2 and cyclin D3 Ab (b).
Figure 7
Cyclin D3-and cyclin D2-dependent kinase activity in B-CLL cells stimulated with DSP30 and IL-2. Cell lysates of B-CLL cells cultured for up to 72 h with DSP30 and IL-2 were immunoprecipitated with cyclin D2 and cyclin D3 Ab and kinase activity was assayed using pRB as a substrate as described in Materials and methods. Total cellular extracts from proliferating Raji cells were immunoprecipitated with an irrelevant rabbit anti IgM Ab and cyclin D3 Ab and were included as a negative and positive control, respectively. strictly dependent on the CpG motif and costimulation of the non-CpG-ODN pZ2 with IL-2 or CD40 ligand results in a moderate and delayed stimulation 21, 24 with upregulation of cyclin D2 and cyclin D3 at later time-points (Figure 3a) . Stimulation by oligonucleotides lacking a CpG motif might be attributed to an unspecific effect mediated by the phosphothioate backbone, 25 unspecific effects of non-CpG-ODN at higher concentrations 29 or other stimulatory oligonucleotide sequences. 30 The cdk inhibitor p27 is of pivotal importance in regulating progression through the cell cycle in lymphocytes 13, 31 and either reduced or increased expression is involved in the pathophysiology of lymphoproliferative disorders. 32, 33 P27 is overexpressed in B-CLL cells and in contrast to solid tumors, high p27 levels were associated with a poorer outcome. [7] [8] [9] We observed a rapid downregulation of p27 in response to the CpG-ODN DSP30 in B-CLL cells that was much more pronounced than in normal B cells (Figures 2 and 5 ). Even after culture with IL-2 alone or the non-CpG-ODN pZ2, when no significant thymidine incorporation was observed, a moderate reduction of p27 levels occurred. This is not simply due to spontaneous degradation in vitro which has been described in mantle cell lymphoma, 34 because p27 protein levels remained constant when B-CLL cells were cultured in medium alone (Figure 4b ). Elimination of p27 has been reported to be mediated by ubiquitin-dependent degradation, 35 and the upregulation of the ubiquitin system that has been recently reported in B-CLL cells 36 might provide an explanation for the rapid reduction of p27 levels upon stimulation of B-CLL cells. However, loss of p27 was not associated with thymidine incorporation unless expression of D-type cyclins was observed (Figures 2-4) , which are needed to activate cyclindependent kinases and mediate phosphorylation of target proteins.
D-type cyclins regulate early G1 progression and are thought to be growth factor sensors linking extracellular signals to the cell cycle. 18 The prominent role of cyclin D3 in normal human B cells has been clearly established, 12,13 but little is known about regulation of D-type cyclins in proliferating malignant B cells.
In contrast to normal B cells, stimulation with DSP30 alone resulted in only weak induction of cyclin D3 in B-CLL cells, but a stronger cyclin D2 expression was noted (Figure 2b ). This finding is supported by the observation that cyclin D2, mRNA but not cyclin D3 mRNA, is overexpressed in B-CLL cells. 4 Addition of IL-2 dramatically increased thymidine incorporation and the expression of cyclin D2 in all B-CLL samples tested, while cyclin D3 was only moderately regulated in two out of four samples (Figure 2b and data not shown). Previous reports have demonstrated poor expression of cyclin D1 in B-CLL, 37 and we observed no regulation in activated B-CLL cells (Figure 2) . In cntrast to previous reports in normal B cells, 12, 13 cyclin D2 and cyclin D3 were both associated with cdk4 but not cdk6, which is the catalytic partner of cyclin D3 in normal B cells. 12, 13 Both cyclin-cdk complexes were functional and able to phosphorylate the RB protein in vitro (Figures 6b and 7) . These results suggest that cyclin D2 and D3 are both key regulatory cyclins in B-CLL cells with cdk4 as the correspoding catalytic partner. Little is known about the signal transduction pathways that control expression of delayed early genes, such as D-type cyclins. Recent research has demonstrated that cyclin D2 expression is controlled by multiple signaling pathways including the Srcand the MAPK/ERK kinase pathway 38 and the c-myc pathway. 39, 40 In addition, cdk4, which is highly expressed in resting B-CLL cells and the catalytic partner of cyclin D2 and cyclin D3 has been identified as a target of c-myc. 41 Although constitutively activated signaling pathways including STAT serine phosphorylation 42 and enhanced nuclear NF-kappaBbinding activity 43 have been described in B-CLL, the biological significance of these findings remains to be determined.
Phosphorylation of the RB protein identifies the restriction point in G1 of the cell cycle. 10 It is frequently inactivated in human tumors, 44 and expression of the RB protein has been described to be altered in B-CLL. 45 In contrast to these observations, RB protein phosphorylation and induction was observed in B-CLL cells stimulated with DSP30 and was strongly enhanced when IL-2 was added to the cultures in all samples tested (Figure 2b) . When an appropriate second signal is provided, the proliferative hyporesponsiveness of B-CLL cells can be overcome and rapid phosphorylation of the RB protein is accompanied by a large fraction of B-CLL cells in S/G2/M phase of the cell cycle.
Cycling B-CLL cells have been identified in so-called proliferation centers in lymph nodes and the bone marrow, 32 where they might receive proliferation signals from the microenvironment. [46] [47] [48] Stimulation of B-CLL cells with CpG-ODN and IL-2 forces a large proportion of B-CLL cells to traverse the cell cycle. Therefore it seems to be a valuable in vitro model to investigate cell cycle regulation and signal transduction in the proliferating compartment of B-CLL. Further in vitro studies will deal with the effect of chemotherapy as well as the new class of cell cycle inhibitors 49 and signal transduction inhibitors that are entering clinical trials 50 on proliferating B-CLL cells. We conclude that improving our knowledge of cell cycle regulation in B-CLL not only contributes to our understanding of B-CLL pathophysiology, but might ultimately lead to the identification of new therapeutic targets.
